Select forms of tumor cell apoptosis induce dendritic cell maturation

Journal of Leukocyte Biology

Volumn 77, Issue 3, 2005, Pages 361-368

  Demaria, Sandra ^a   Santori, Fabio R ^a   Ng, Bruce ^a   Liebes, Leonard ^a   Formenti, Silvia C ^a   Vukmanovic, Stanislav ^a,b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

Chemotherapy; Costimulation; Fas CD95; Tumor immunity

Indexed keywords

B7 ANTIGEN; BORTEZOMIB; CD40 ANTIGEN; CD86 ANTIGEN; FAS ANTIGEN;

ANIMAL CELL; ANTIGEN PRESENTATION; APOPTOSIS; ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CARCINOMA CELL; CELL ACTIVITY; CELL MATURATION; CHEMOTHERAPY; CONTROLLED STUDY; DENDRITIC CELL; DRUG MECHANISM; IMMUNE RESPONSE; INFLAMMATION; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR IMMUNITY; ULTRAVIOLET IRRADIATION;

ANIMALS; ANTIGENS, CD95; ANTINEOPLASTIC AGENTS; APOPTOSIS; BORONIC ACIDS; CELL LINE, TUMOR; DENDRITIC CELLS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; PYRAZINES; SIGNAL TRANSDUCTION; TAMOXIFEN;

EID: 14244262560     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0804478     Document Type: Article

References (36)

1. Albert, M. L., Sauter, B., Bhardwaj, N. (1998) Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392, 86-89.
2. Sauter, B., Albert, M. L., Francisco, L., Larsson, M., Somersan, S., Bhardwaj, N. (2000) Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J. Exp. Med. 191, 423-433.
3. Gallucci, S., Lolkema, M., Matzinger, P. (1999) Natural adjuvants: endogenous activators of dendritic cells. Nat. Med. 5, 1249-1255.
4. Basu, S., Binder, R. J., Suto, R., Anderson, K. M., Srivastava, P. K. (2000) Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-κB pathway. Int. Immunol. 12, 1539-1546.
5. Steinman, R. M., Turley, S., Mellman, I., Inaba, K. (2000) The induction of tolerance by dendritic cells that have captured apoptotic cells. J. Exp. Med. 191, 411-416.
6. Dhodapkar, M. V., Steinman, R. M., Krasovsky, J., Munz, C., Bhardwaj, N. (2001) Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J. Exp. Med. 193, 233-238.
7. Kaufmann, S. H., Earnshaw, W. C. (2000) Induction of apoptosis by cancer chemotherapy. Exp. Cell Res. 256, 42-49.
8. Leitner, W. W., Ying, H., Driver, D. A., Dubensky, T. W., Restifo, N. P. (2000) Enhancement of tumor-specific immune response with plasmid DNA replicon vectors. Cancer Res. 60, 51-55.
9. Chattergon, M. A., Kim, J. J., Yang, J-S., Robinson, T. M., Lee, D. J., Dentchev, T., Wilson, D. M., Ayyavoo, V., Weiner, D. B. (2000) Targeted antigen delivery to antigen-presenting cells including dendritic cells by-engineered Fas-mediated apoptosis. Nat. Biotechnol. 18, 974-979.
10. Sasaki, S., Amara, R. R., Oran, A. E., Smith, J. M., Robinson, H. L. (2001) Apoptosis-mediated enhancement of DNA-raised immune responses by mutant caspases. Nat. Biotechnol. 19, 543-547.
11. Demaria, S., Volm, M. D., Shapiro, R. L., Yee, H. T., Oratz, R., Formenti, S. C., Muggia, F., Symmans, W. F. (2001) Development of tumor infiltrating lymphocytes in breast cancer after neoadjuvant paclitaxel chemotherapy. Clin. Cancer Res. 7, 3025-3030.
12. Nowak, A. K., Lake, R. A., Marzo, A. L., Scott, B., Heath, W. R., Collins, E. J., Frelinger, J. A., Robinson, B. W. S. (2003) Induction of tumor cell apoptosis in vivo increases tumor antigen cross-presentation, cross-priming rather than cross-tolerizing host tumor-specific CD8 T cells. J. Immunol. 170, 4905-4913.
13. Littlewood, T. D., Hancock, D. C., Danielian, P. S., Parker, M. G., Evan, G. I. (1995) A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res. 23, 1686-1690.
14. Cutrupi, S., Baldanzi, G., Gramaglia, D., Maffè, A., Schaap, D., Giraudo, E., van Blitterswijk, W., Bussolino, F., Comoglio, P. M., Graziani, A. (2000) Src-mediated activation of α-diacylglycerol kinase is required for hepatocyte growth factor-induced cell motility. EMBO J. 19, 4614-4622.
15. Lutz, M. B., Kukutsch, N., Ogilvie, A. L. J., Rosner, S., Koch, F., Romani, N., Schuler, G. (1999) An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223, 77-92.
16. Rovere, P., Vallinoto, C., Bondanza, A., Crosti, M. C., Rescigno, M., Ricciardi-Castagnoli, P., Rugarli, C., Manfredi, A. A. (1998) Cutting edge: bystander apoptosis triggers dendritic cell maturation and antigen-presenting function. J. Immunol. 161, 4467-4471.
17. Tada, H., Shiho, O., Kuroshima, K., Koyama, M., Tsukamoto, K. (1986) An improved colorimetric assay for interleukin-2. J. Immunol. Methods 93, 157-165,
18. Adams, J., Palombella, V. J., Sausville, E. A., Johnson, J., Destree, A., Lazarus, D. D., Maas, J., Pien, C. S., Prakash, S., Elliott, P. J. (1999) Proteasome inhibitors: a novel class of potent and effective antitumor agents. Cancer Res. 59, 2615-2622.
19. Adams, J. (2002) Development of the proteasome inhibitor PS-341. Oncologist 7, 9-16.
20. Cortes, J., Thomas, D., Koller, C., Giles, F., Estey, E., Faderl, S., Garcia-Manero, G., McConkey, D., Patel, G., Guerciolini, R., Wright, J., Kantarjian, H. (2004) Phase I study of bortezomib in refractory or relapsed acute leukemias. Clin. Cancer Res. 10, 3371-3376.
21. Mitsiades, N., Mitsiades, C. S., Poulaki, V., Chauhan, D., Fanourakis, G., Gu, X., Bailey, C., Joseph, M., Libermann, T. A., Treon, S. P., Munshi, N. C., Richardson, P. G., Hideshima, T,. Anderson, K. C. (2002) Molecular sequelae of proteasome inhibition in human multiple myeloma cells. Proc. Natl. Acad. Sci. USA 99, 14374-14379.
22. Scaffidi, C., Fulda, S., Srinivasan, A., Friesen, C., Li, F., Tomaselli, K. J., Debatin, K. M., Krammer, P. H., Peter, M. E. (1998) Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 17, 1675-1687.
23. Penninger, J. M., Kroemer, G. (2003) Mitochondria, AIF and caspases - rivaling for cell death execution. Nat. Cell Biol. 5, 97-99.
24. Li, D., Das, S., Yamada, T., Samuels, H. H. (2004) The NRIF3 family of transcriptional coregulators induces rapid and profound apoptosis in breast cancer cells. Mol. Cell. Biol. 24, 3838-3848.
25. d-restricted CTL epitope. Gene Ther. 7, 2036-2040.
26. Restifo, N. P. (2000) Building better vaccines: how apoptotic cell death can induce inflammation and activate innate and adaptive immunity. Curr. Opin. Immunol. 12, 597-603.
27. Schwarz, T. (2002) Photoimmunosuppression. Photodermatol. Photoimmunol. Photomed. 18, 141-145.
28. Degterev, A., Boyce, M., Yuan, J. (2003) A decade of caspases. Oncogene 22, 8543-8567.
29. Feng, H., Zeng, Y., Graner, M. W., Katsanis, E. (2002) Stressed apoptotic tumor cells stimulate dendritic cells and induce specific cytotoxic T cells. Blood 100, 4108-4115.
30. Susin, S. A., Lorenzo, H. K., Zamzami, N., Marzo, I., Snow, B. E., Brothers, G. M., Mangion, J., Jacotot, E., Costantini, P., Loeffler, M., Larochette, N., Goodlett, D. R., Aebersold, R., Siderovski, D. P., Penninger, J. M., Kroemer, G. (1999) Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397, 441-446.
31. Cande, C., Cohen, I., Daugas, E., Ravagnan, L., Larochette, N., Zamzami, N., Kroemer, G. (2002) Apoptosis-inducing factor (AIF): a novel caspase-independent death effector released from mitochondria. Biochimie 84, 215-222.
32. Lassus, P., Opitz-Araya, X., Lazebnik, Y. (2002) Requirement for caspase-2 in stress-induced apoptosis before mitochondrial permeabilization. Science 297, 1352-1354.
33. Kumar, S., Vaux, D. L. (2002) A Cinderella caspase takes center stage. Science 297, 1290-1291.
34. Hawiger, D., Inaba, K., Dorsett, Y., Guo, M., Mahnke, K., Rivera, M., Ravetch, J. V., Steinman, R. M., Nussenzweig, M. C. (2001) Dendritic cells induce peripheral T cell unresponsiveness under steady-state conditions in vivo. J. Exp. Med. 194, 769-779.
35. Sotomayor, E. M., Borrello, I., Rattis, F. M., Cuenca, A. G., Abrams, J., Staveley-O'Carroll, K., Levitsky, H. I. (2001) Cross-presentation of tumor antigens by bone marrow-derived antigen-presenting cells is the dominant mechanism in the induction of T-cell tolerance during B-cell lymphoma progression. Blood 98, 1070-1077.
36. Cuenca, A. G., Cheng, F., Wang, H., Brayer, J., Horna, P., Gu, L., Bien, H., Borrello, I. M., Levitsky, H. I., Sotomayor, E. M. (2003) Extra-lymphatic solid tumor growth is not immunologically ignored and results in early induction of antigen-specific T-cell anergy: dominant role of cross-tolerance to tumor antigens. Cancer Res. 63, 9007-9015.